Clinical Trials | May 20, 2023
Moderna presents Phase 1/2 of MRNA-3927at 2023 ASGCT Meeting
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
The facility will have a capacity to manufacture upto 3 million tubes monthly
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Subscribe To Our Newsletter & Stay Updated
